Global Vaccine Adjuvants Market Trends, Analysis, Growth, and Forecast: 2017 to 2026

MarketResearch.biz delivers in-depth insights on the global vaccine adjuvants market in its upcoming report titled, “Global Vaccine Adjuvants Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global vaccine adjuvants market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global vaccine adjuvants market report has been segmented on the basis of product type, route of administration, disease type, application, and region.

A vaccine adjuvant enhances the ability to induce protection against infection and activates the immune systems. This response is mediated by B lymphocytes and T lymphocytes. Furthermore, vaccine adjuvant develops long term protective immunity and requires smaller amount of inactivated bacteria and virus to be used in vaccines. Adjuvant vaccines improve the efficacy of vaccines in infants, the elderly population, as the antigen delivery systems for the uptake of antigens is by the mucosa.

Increasing number of cases of infectious diseases and cancer such as cervical cancer, liver cancer etc. is expected to drive the market for global vaccine adjuvants market over the forecast period. Moreover, rising awareness about vaccination coupled with several government and non-profit organizations providing education and funding for the development of vaccine adjuvants, is anticipated to further drive growth of the global vaccine adjuvants market over the forecast period.

However, high cost incurred in research and development, toxicity of vaccines, and stringent government regulation are factors limiting the growth of market over the forecast period.

Development of cost effective vaccine having longer shelf life is expected to create new opportunities for major players operating in the global vaccine adjuvants market over the forecast period.

North America market dominates the global vaccine adjuvants market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of well-developed healthcare infrastructure, skilled labors in the region. Europe accounts for second-largest revenue share contribution to the global vaccine adjuvants market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Europe is projected to register comparatively faster growth in terms of revenue over the next 10 years owing to the improving healthcare infrastructure, increasing government funding for adjuvant vaccine development, increasing prevalence of infectious diseases and growing number of contract research   organization in the region.

Global vaccine adjuvants market segmentation, by product type:

• Pathogen
• Adjuvant Emulsion
• Particulate
• Combination
• Others

Global vaccine adjuvants market segmentation, by route of administration:

• Oral
• Intradermal
• Intranasal
• Intramuscular
• Others

Global vaccine adjuvants market segmentation, by disease type:

• Infectious Disease
• Cancer
• Others

Global vaccine adjuvants market segmentation, by application:

• Human Vaccine Adjuvants
• Veterinary Vaccine Adjuvants

Global vaccine adjuvants market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Brenntag Biosector
• CSL Limited
• Seppic Inc.
• Agenus, Inc.
• Novavax, Inc.
• SPI Pharma, Inc.
• Invivogen
• Avanti Polar Lipids, Inc.
• MVP Laboratories, Inc.
• OZ Biosciences